FGF23 beyond mineral metabolism: a bridge to cardiovascular disease.
作者信息
Larsson Tobias E
出版信息
Clin J Am Soc Nephrol. 2011 Dec;6(12):2735-7. doi: 10.2215/CJN.10711011.
Abstract
摘要
相似文献
1
FGF23 beyond mineral metabolism: a bridge to cardiovascular disease.成纤维细胞生长因子23超出矿物质代谢范畴：连接心血管疾病的桥梁
Clin J Am Soc Nephrol. 2011 Dec;6(12):2735-7. doi: 10.2215/CJN.10711011.
2
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.成纤维细胞生长因子 23 在腹膜透析患者中的研究。
Clin J Am Soc Nephrol. 2011 Nov;6(11):2688-95. doi: 10.2215/CJN.04290511. Epub 2011 Sep 8.
3
Circulating fibroblast growth factor 23 in patients with end-stage renal disease treated by peritoneal dialysis is intact and biologically active.在接受腹膜透析治疗的终末期肾病患者中，循环成纤维细胞生长因子 23 是完整且具有生物活性的。
J Clin Endocrinol Metab. 2010 Feb;95(2):578-85. doi: 10.1210/jc.2009-1603. Epub 2009 Dec 4.
4
Relationship between residual renal function and serum fibroblast growth factor 23 in patients on peritoneal dialysis.腹膜透析患者残余肾功能与血清成纤维细胞生长因子23的关系
Ther Apher Dial. 2014 Oct;18(5):383-90. doi: 10.1111/1744-9987.12170. Epub 2014 Mar 27.
5
Determinants of fibroblast growth factor-23 and parathyroid hormone variability in dialysis patients.透析患者成纤维细胞生长因子 23 和甲状旁腺激素变异性的决定因素。
Am J Nephrol. 2013;37(5):462-71. doi: 10.1159/000350537. Epub 2013 Apr 27.
6
Fibroblast growth factor 23, but not parathyroid hormone, is associated with urinary phosphate regulation in patients on peritoneal dialysis.成纤维细胞生长因子23而非甲状旁腺激素与腹膜透析患者的尿磷调节有关。
Ther Apher Dial. 2015 Feb;19(1):73-80. doi: 10.1111/1744-9987.12221. Epub 2014 Sep 4.
7
Clearance of Sclerostin, Osteocalcin, Fibroblast Growth Factor 23, and Osteoprotegerin by Dialysis.透析清除骨硬化蛋白、骨钙素、成纤维细胞生长因子 23 和骨保护素。
Blood Purif. 2017;44(2):122-128. doi: 10.1159/000465513. Epub 2017 May 30.
8
Fibroblast growth factor 23 (FGF23) level is associated with ultrafiltration rate in patients on hemodialysis.成纤维细胞生长因子 23（FGF23）水平与血液透析患者的超滤率相关。
Heart Vessels. 2021 Mar;36(3):414-423. doi: 10.1007/s00380-020-01704-y. Epub 2020 Sep 30.
9
Fibroblast Growth Factor 23 and Risk of CKD Progression in Children.成纤维细胞生长因子23与儿童慢性肾脏病进展风险
Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1989-1998. doi: 10.2215/CJN.02110216. Epub 2016 Aug 25.
10
Short-Term Effects of Very-Low-Phosphate and Low-Phosphate Diets on Fibroblast Growth Factor 23 in Hemodialysis Patients: A Randomized Crossover Trial.极低磷和低磷饮食对血液透析患者成纤维细胞生长因子 23 的短期影响：一项随机交叉试验。
Clin J Am Soc Nephrol. 2019 Oct 7;14(10):1475-1483. doi: 10.2215/CJN.04250419. Epub 2019 Sep 13.
引用本文的文献
1
Markers of Bone Mineral Metabolism and Cardiac Structure and Function in Perinatally HIV-Infected and HIV-Exposed but Uninfected Children and Adolescents.围生期感染人类免疫缺陷病毒（HIV）及HIV 暴露但未感染儿童和青少年的骨矿物质代谢和心脏结构与功能标志物。
J Acquir Immune Defic Syndr. 2019 Jun 1;81(2):238-246. doi: 10.1097/QAI.0000000000002007.
2
Hemodialysis is associated with higher serum FGF23 level when compared with peritoneal dialysis.与腹膜透析相比，血液透析与更高的血清成纤维细胞生长因子23（FGF23）水平相关。
Int Urol Nephrol. 2017 Sep;49(9):1653-1659. doi: 10.1007/s11255-017-1605-z. Epub 2017 Apr 28.
3
Association of serum intact fibroblast growth factor 23 with left ventricular mass and different echocardiographic findings in patients on hemodialysis.血液透析患者血清完整成纤维细胞生长因子23与左心室质量及不同超声心动图表现的相关性
J Transl Int Med. 2016 Sep 1;4(3):135-141. doi: 10.1515/jtim-2016-0030. Epub 2016 Sep 23.
4
Upregulation of Oxidative Stress Related Genes in a Chronic Kidney Disease Attributed to Specific Geographical Locations of Sri Lanka.斯里兰卡特定地理位置所致慢性肾脏病中氧化应激相关基因的上调
Biomed Res Int. 2016;2016:7546265. doi: 10.1155/2016/7546265. Epub 2016 Nov 16.
5
Plasma Fibroblast Growth Factor 23: Clinical Correlates and Association With Cardiovascular Disease and Mortality in the Framingham Heart Study.血浆成纤维细胞生长因子23：弗雷明汉心脏研究中的临床关联以及与心血管疾病和死亡率的关系
J Am Heart Assoc. 2016 Jul 6;5(7):e003486. doi: 10.1161/JAHA.116.003486.
6
Biomarkers Associated with Vascular Calcification in Peritoneal Dialysis.与腹膜透析血管钙化相关的生物标志物
Perit Dial Int. 2016 May-Jun;36(3):262-8. doi: 10.3747/pdi.2014.00250. Epub 2015 Aug 20.
7
Potential Predictors of Plasma Fibroblast Growth Factor 23 Concentrations: Cross-Sectional Analysis in the EPIC-Germany Study.血浆成纤维细胞生长因子23浓度的潜在预测因素：德国EPIC研究中的横断面分析
PLoS One. 2015 Jul 20;10(7):e0133580. doi: 10.1371/journal.pone.0133580. eCollection 2015.
8
A comparison of calcium acetate/magnesium carbonate and sevelamer-hydrochloride effects on fibroblast growth factor-23 and bone markers: post hoc evaluation from a controlled, randomized study.醋酸钙/碳酸镁和盐酸司维拉姆对成纤维细胞生长因子 23 和骨标志物影响的比较：一项对照、随机研究的事后评估。
Nephrol Dial Transplant. 2013 Sep;28(9):2383-92. doi: 10.1093/ndt/gft203. Epub 2013 Jun 19.
本文引用的文献
1
FGF23 induces left ventricular hypertrophy.成纤维细胞生长因子 23 可诱导左心室肥厚。
J Clin Invest. 2011 Nov;121(11):4393-408. doi: 10.1172/JCI46122. Epub 2011 Oct 10.
2
Expression of FGF23/KLOTHO system in human vascular tissue.成纤维细胞生长因子 23/klotho 系统在人血管组织中的表达。
Int J Cardiol. 2013 Apr 30;165(1):179-83. doi: 10.1016/j.ijcard.2011.08.850. Epub 2011 Sep 25.
3
Fibroblast growth factor 23 in patients undergoing peritoneal dialysis.成纤维细胞生长因子 23 在腹膜透析患者中的研究。
Clin J Am Soc Nephrol. 2011 Nov;6(11):2688-95. doi: 10.2215/CJN.04290511. Epub 2011 Sep 8.
4
Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.成纤维细胞生长因子 23 与慢性肾脏病患者的死亡率和终末期肾病风险。
JAMA. 2011 Jun 15;305(23):2432-9. doi: 10.1001/jama.2011.826.
5
Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality.成纤维细胞生长因子 23 水平升高是导致肾移植失败和死亡的危险因素。
J Am Soc Nephrol. 2011 May;22(5):956-66. doi: 10.1681/ASN.2010080894. Epub 2011 Mar 24.
6
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease.成纤维细胞生长因子 23 在慢性肾脏病中比甲状旁腺激素和磷酸盐更早升高。
Kidney Int. 2011 Jun;79(12):1370-8. doi: 10.1038/ki.2011.47. Epub 2011 Mar 9.
7
Klotho deficiency causes vascular calcification in chronic kidney disease.Klotho 缺乏导致慢性肾脏病中的血管钙化。
J Am Soc Nephrol. 2011 Jan;22(1):124-36. doi: 10.1681/ASN.2009121311. Epub 2010 Nov 29.
8
Circulating fibroblast growth factor-23 is associated with fat mass and dyslipidemia in two independent cohorts of elderly individuals.循环成纤维细胞生长因子 23 与老年人群中两个独立队列的脂肪量和血脂异常相关。
Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):219-27. doi: 10.1161/ATVBAHA.110.214619. Epub 2010 Oct 21.
9
Direct evidence for a causative role of FGF23 in the abnormal renal phosphate handling and vitamin D metabolism in rats with early-stage chronic kidney disease.直接证据表明，在早期慢性肾脏病大鼠中，FGF23 在异常肾脏磷酸盐处理和维生素 D 代谢中起因果作用。
Kidney Int. 2010 Nov;78(10):975-80. doi: 10.1038/ki.2010.313. Epub 2010 Sep 15.
10
PTH increases FGF23 gene expression and mediates the high-FGF23 levels of experimental kidney failure: a bone parathyroid feedback loop.甲状旁腺激素增加成纤维细胞生长因子 23 基因表达并介导实验性肾衰竭中的高成纤维细胞生长因子 23 水平：骨甲状旁腺反馈回路。
Am J Physiol Renal Physiol. 2010 Oct;299(4):F882-9. doi: 10.1152/ajprenal.00360.2010. Epub 2010 Aug 4.
Zotero 插件